| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.762 | - | - | 48.635 | 97.020 | 103.182 | 93.966 | 87.936 | 118.262 | 103.488 |
| Total Income - EUR | 23.268 | - | - | 48.635 | 97.020 | 103.182 | 93.966 | 87.936 | 118.262 | 103.488 |
| Total Expenses - EUR | 11.471 | - | - | 32.121 | 79.596 | 29.141 | 61.696 | 64.934 | 58.053 | 39.373 |
| Gross Profit/Loss - EUR | 11.797 | - | - | 16.513 | 17.424 | 74.041 | 32.270 | 23.002 | 60.209 | 64.115 |
| Net Profit/Loss - EUR | 11.144 | - | - | 15.945 | 16.454 | 73.009 | 31.349 | 22.122 | 59.026 | 61.073 |
| Employees | 1 | - | - | 0 | 0 | 2 | 4 | 2 | 2 | 1 |
Check the financial reports for the company - Medvalens Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.551 | - | - | 3.148 | 2.050 | 7.412 | 16.545 | 73.359 | 7.248 | 24.702 |
| Current Assets | 10.463 | - | - | 27.253 | 45.158 | 17.249 | 19.377 | 3.234 | 29.396 | 20.218 |
| Inventories | 36 | - | - | 0 | 0 | 0 | 0 | 177 | 0 | 0 |
| Receivables | 9.831 | - | - | 26.969 | 32.908 | 6.154 | 6.958 | 2.759 | 23.156 | 139 |
| Cash | 595 | - | - | 284 | 12.250 | 11.095 | 12.420 | 297 | 6.240 | 20.080 |
| Shareholders Funds | 14.357 | - | - | 30.099 | 45.970 | 18.959 | 34.528 | 57.425 | 31.981 | 42.993 |
| Social Capital | 45 | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 658 | - | - | 302 | 1.238 | 5.702 | 1.395 | 19.168 | 4.768 | 1.927 |
| Income in Advance | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medvalens Srl